secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2022-08-17T23:59:59+00:00
Accession:  0001193125-22-223286
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna appoints James Mock as CFO effective Sept 6, 2022; David Meline retires
-------------------------------------------------------------------------------

- James Mock named CFO, starting Sept 6, 2022; will report to CEO Stéphane Bancel.
- David Meline retires as CFO same date but remains as consultant for transition.
- Mock receives $750,000 base salary, $1M signing bonus, $6M equity grant (4-yr vest).
- Mock previously SVP & CFO of PerkinElmer; 20 years at GE before that.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000119312522223286/0001193125-22-223286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000119312522223286/d390105d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-223286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer